Factors influencing the switch in the use of antihypertensive medications

International Journal of Clinical Practice

Volumn 59, Issue 1, 2005, Pages 85-91

  Chou, Chih Chieh ^a   Lee, M S ^b   Ke, C H ^a   Chuang, M H ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Adherence; Ambulatory care; Hypertension; Medication switch; National Health Insurance

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG CLASSIFICATION; DRUG RESPONSE; DRUG USE; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POPULATION DISTRIBUTION; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TAIWAN;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE MONITORING, AMBULATORY; CALCIUM CHANNEL BLOCKERS; CONTINUITY OF PATIENT CARE; DIURETICS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PATIENT COMPLIANCE; PHYSICIAN'S PRACTICE PATTERNS;

EID: 13844307773     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2005.00436.x     Document Type: Article

References (29)

1. Hansson L. 'Why don't you do as I tell you?' Compliance and antihypertensive regimens. Int J Clin Pract 2002; 56: 191-6.
2. Mettimano M, Pichetti F, Fazzari L et al. Combination therapy with beta-adrenergic blockade and amlodipine as second line treatment in essential hypertension. Int J Clin Pract 2000; 54: 424-8.
3. Philipp T, Anlauf M, Distler A et al. Randomised, double blind, multicentre comparison of hydrochlorthiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. Br Med J 1997; 315: 154-9.
4. Gong L, Zwang W, Zhu Y et al. Shanghia trial of nifedipine in the elderly (STONE) study. J Hypertens 1996; 14: 1237-46.
5. Guidelines Sub Committee. European Society of Hypertension - European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-53.
6. Frijling BD, Spies TH, Lobo CM et al. Blood pressure control in treated hypertensive patients: clinical performance of general practitioners. Br J General Pract 2001; 51: 9-14.
7. Cranney M, Barton S, Walley T. Addressing barriers to change: an RCT of practice-based education to improve the management of hypertension in the elderly. Br J Gen Pract 1999; 49: 522-6.
8. Miller NH, Hill M, Kottke T, Ockene IS. The multiple compliance challenge: recommendations for a call to action: a statement for healthcare professionals. Circulation 1997; 95: 1085-90.
9. Chou CC, Lee MS, Ke CH, Chiang MS. Prescription patterns of hypertension - National Health Insurance in Taiwan. J Chin Med Assoc 2004; 67: 123-30.
10. American Medical Association. Physicians' Current Procedural Terminology Chicago: American Medical Association, 1997.
11. Bureau of National Health Insurance. Guidelines of Filing Claims for Health Service Providers. Taipei, Taiwan: Bureau of National Health Insurance, 1995.
12. Bureau of National Health Insurance. National Health Insurance. Annual Statistical Report 1998. Taipei, Taiwan: Bureau of National Health Insurance, 1999.
13. International Classification of Diseases, 9th revision, Clinical Modification, 6th edn. Los Angeles, USA: Practice Management Information Corporation 2000: 277-80.
14. Guidelines Sub-Committee. World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17: 151-83.
15. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413-46.
16. Cottrell K. Experts discuss cost-effective treatment of hypertension during world conference in Canada. Can Med Assoc J 1995; 153: 1332-5.
17. Bureau of National Health Insurance. Listing medicines of National Health Insurance. Taipei, Taiwan: Bureau of National Health Insurance. http://www.nhi.gov.tw/download/download.htm (accessed on August 1 2002).
18. Chou CC, Lee MS. An assessment of the refill of chronic disease prescriptions in a medical center. Chin J Fam Med 1994; 4: 209-18 (in Chinese).
19. Guidelines Sub-Committee. Guidelines for the management of mild hypertension: memorandum from a World Health Organization - International Society of Hypertension Meeting. J Hypertens 1993; 11: 905-18.
20. Schachter M, Mitchell G, Niziol C et al. Antihypertensive efficacy of moxonidine in primary care: a 'real-life' study. Int J Clin Pract 2003; 57: 479-82.
21. Larochelle P, Flack MJ, Marbury CT et al. Effects and tolerability of irbesartan versus enalapril in patients with severe hypertension. Am J Cardiol 1997; 80: 1613-5.
22. McCombs JS, Nichol MB, Newman CM, Sclar DA. The costs of interrupting antihypertensive drug therapy in a Medicaid population. Med Care 1994; 32: 21-6.
23. National Intervention Cooperative Study in Elderly Hypertensives Study, Tokyo, Japan. Randomized double-blind comparison of a calcium antagonist and a diuretic in elderly hypertensives. Hypertension 1999; 34: 1129-33.
24. Eguchi K, Kario K, Hoshide Y et al. Comparison of valsartan and amlodipine on ambulatory and morning blood pressure in hypertensive patients. Am J Hypertens 2004; 17: 112-7.
25. Brown NJ, Vaughan DE. Angiotension-converting enzyme inhibitors. Circulation 1998; 97: 1411-20.
26. Chan P, Tomlinson B, Huang TY, Ko JT, Lin TS, Lee YS. Double-blind comparison of losartan, lisinopril, and metolazone in elderly hypertensive patients with previous angiotensin-converting enzyme inhibitor-induced cough. J Clin Pharmacol 1997; 37: 253-7.
27. Pear R. Drug makers battle plan to curb rewards for doctors. NY Times, December 26, 2002, http://www.globalaging.org/health/us/curb2.htm (accessed on February 10, 2003).
28. Freis ED. Improving treatment effectiveness in hypertension. Arch Intern Med 1999; 159: 2517-21.
29. Graves JW. Management of difficult to control hypertension. Mayo Clin Proc 2000; 75: 278-84.